Review reports the development trajectory of twenty commercial gene therapies across global markets, highlighting milestones in clinical translation for genetic disorders.
. This article reviews the history and development of twenty approved human gene and cell-based gene therapy products that have been approved up-to-now in clinic and markets of mainly North America, Europe and Asia.
No takes yet. Share an insight, caveat, or question.
Shahryari et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: